CD274 and ischemic stroke: PD‐L1 plays a critical role in ischemic stroke recovery, with PD‐L1 mAb treatment demonstrating age‐dependent therapeutic efficacy by enhancing blood–brain barrier integrity, reducing neuroinflammation and apoptosis, and modulating peripheral immune responses.